Insmed
INSM
INSM
176 hedge funds and large institutions have $2.35B invested in Insmed in 2019 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 53 increasing their positions, 56 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.95% less ownership
Funds ownership: 111.01% → 110.06% (-0.95%)
5% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 56
18% less call options, than puts
Call options by funds: $16.4M | Put options by funds: $20M
Holders
176
Holding in Top 10
6
Calls
$16.4M
Puts
$20M
Top Buyers
| 1 | +$19.7M | |
| 2 | +$15.7M | |
| 3 | +$10.3M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$9.59M |
| 5 |
Barclays
London,
United Kingdom
|
+$9.44M |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$14.5M | |
| 3 | -$13.8M | |
| 4 |
O
OrbiMed
New York
|
-$12M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11.3M |